News & Updates

Patients with venous thromboembolism (VTE) who are new users of apixaban are less likely to experience recurrent VTE and bleeding than new users of rivaroxaban, a study has shown.

In a cohort of veterans with COVID-19, former smokers are at higher risk of 30-day mortality compared with current smokers and nonsmokers, as reported in a study.

Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.

Diabetes does not appear to predispose SARS-CoV-2–infected patients to long-term post-COVID-19 symptoms, a study reports.

The incidence of nonalcoholic fatty liver disease (NAFLD) is high among individuals with inflammatory bowel disease (IBD), according to data presented at AIBD 2021.

Hypertension and proteinuria contribute to an increased risk of atrial fibrillation (AF) as well as stroke, heart failure admission, and cardiovascular death in older adults, and such risk is greater when both conditions are present, according to a study.